Hsbc Holdings PLC Arcturus Therapeutics Holdings Inc. Transaction History
Hsbc Holdings PLC
- $168 Billion
- Q4 2024
A detailed history of Hsbc Holdings PLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 25,368 shares of ARCT stock, worth $357,181. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,368
Previous 22,695
11.78%
Holding current value
$357,181
Previous $526,000
18.25%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$66.1 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$37.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$29.1 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$29.1 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$27.2 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $374M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...